Empirical antifungal therapy in selected patients with persistent febrile neutropenia. (Q40387020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Empirical antifungal therapy in selected patients with persistent febrile neutropenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

M Aguilar-Guisado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

I Espigado

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Noguer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

R Parody

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J Pachón

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J M Cisneros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

15 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

159-164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2009.125

31 January 2020

exact match

0 references

cites work

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Empirical antifungal therapy in selected patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Opportunistic CNS infection after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

Guidelines for treatment of candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

inferred from DOI database lookup

7 January 2021

based on heuristic

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.125

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/BMT.2009.125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19525983%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 January 2020

0 references

1 reference